noom glp 1 injection Unveils Two New Enterprise Products to Help Employers Noom Launches Microdose GLP-1 Program,

The good news: Help is out there

If side effects dont lessen after a few weeks, talk to your provider about dose adjustments

In theory, if GLP-1s are affecting insulin levels and redirecting glucose into muscles, would they change the distribution pattern of FDG on a scan

8,12,13 A meta-analysis by Ku and Chang 6 reported PASI improvement in both diabetic and nondiabetic groups (over the 6- to 12-week periods of the 4 prospective cohort studies analyzed), with nearly 35% achieving a 75% or greater improvement in PASI (PASI-75) from their respective baselines, and a proposed immunomodulatory mechanism

Whether you view this as a welcome bonus or disguised dose-escalation pricing depends on your perspective